SCHEMBL17875787

SCHEMBL17875787

c1ccc(-c2cc(-c3ccc4c(c3)CSCc3ccc(-c5cc(-c6ccccc6)nc(-c6ccccc6)c5)cc3-4)cc(-c3ccccc3)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.37
KDM4E B2RXH2 1/20 0.37
CYP19A1 P11511 1/20 0.36
MEN1 O00255 6/20 0.36
KMT2A Q03164 6/20 0.36
TDP2 O95551 1/20 0.36
MYC P01106 1/20 0.36
PARP10 Q53GL7 1/20 0.35
PARP11 Q9NR21 1/20 0.35
RAB9A P51151 1/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 3/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
NTSR1 P30989 1/20 0.34
MCL1 Q07820 2/20 0.34
TYRO3 Q06418 1/20 0.34
NTRK2 Q16620 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875757 0.97 CYP19A1 (0.38) MAPTKDM4ECYP19A1MEN1KMT2A
SCHEMBL17875751 0.97 CYP19A1 (0.38) MAPTKDM4ECYP19A1MEN1KMT2A
SCHEMBL17875809 0.94 MAPT (0.40) MAPTKDM4ECYP19A1MEN1KMT2A
SCHEMBL17875810 0.91 CYP19A1 (0.41) MAPTKDM4ECYP19A1MEN1KMT2A
SCHEMBL17875770 0.89 CYP19A1 (0.50) KDM4ECYP19A1TDP2RAB9AALDH1A1
SCHEMBL17875754 0.89 CYP19A1 (0.50) KDM4ECYP19A1TDP2RAB9AALDH1A1
SCHEMBL17875749 0.86 TDP2 (0.44) MAPTKDM4EMEN1KMT2ATDP2
SCHEMBL17875738 0.86 HCRTR1 (0.33) MAPTKDM4EMEN1KMT2AMYC
SCHEMBL17875763 0.86 KMT2A (0.35) MAPTKDM4EMEN1KMT2AMYC
SCHEMBL17875803 0.86 HCRTR1 (0.33) MAPTKDM4EMEN1KMT2AMYC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 MAPT 2144/4885KDM4E 3120/4885CYP19A1 167/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 MAPT 2144/4885KDM4E 3120/4885CYP19A1 167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.